Atherosclerosis: An integrative east-west medicine perspective

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Xu, Hao ^a   Shi, Dazhuo ^a   Chen, Keji ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PAEONIA RADIX; PAEONIFLORIN; SIMVASTATIN;

ATHEROSCLEROSIS; CELL INTERACTION; CHINESE MEDICINE; CORONARY ARTERY OBSTRUCTION; DISEASE COURSE; DISEASE SEVERITY; DRUG ELUTING STENT; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION INHIBITION; VULNERABLE POPULATION;

EID: 84861037885     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/148413     Document Type: Review

References (27)

1. Dobos G., Tao I., The model of Western integrative medicine: the role of Chinese medicine Chinese Journal of Integrative Medicine 2011 17 1 11 20
2. Robinson N., Integrative medicinetraditional Chinese medicine, a model? Chinese Journal of Integrative Medicine 2011 17 1 21 25
3. Xu H., Chen K. J., Integrating traditional medicine with biomedicine towards a patient-centered healthcare system Chinese Journal of Integrative Medicine 2011 17 2 83 84
4. Chen K. J., Shi D. Z., Xu H., L S. Z., Li T. C., Ke Y. N., Zhang M. Z., Lu X. Y., Sun R. Y., You S. J., XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China Chinese Medical Journal 2006 119 1 6 13
5. Shang Q. H., Xu H., Lu X. Y., Wen C., Shi D. Z., Chen K. J., A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients Chinese journal of integrative medicine 2011 17 9 669 674
6. Gao Z. -y., Xu H., Shi D. -z., Wen C., Liu B. -y., Analysis on outcome of 5284 patients with coronary artery disease: the role of integrative medicine. Journal of Ethnopharmacology. In press
7. Lu Z., Kou W., Du B., Wu Y., Zhao S., Brusco O. A., Morgan J. M., Capuzzi D. M., Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction American Journal of Cardiology 2008 101 12 1689 1693
8. Wen C., Xu H., The new strategy for modulating dyslipidemia: consideration from updated understanding on high-density lipoprotein Chinese Journal of Integrative Medicine 2011 17 6 467 470
9. Smith S. C., Risk-reduction therapy: the challenge to change Circulation 1996 93 12 2205 2211
10. Muller J. E., Tofler G. H., Stone P. H., Circadian variation and triggers of onset of acute cardiovascular disease Circulation 1989 79 4 733 743 (Pubitemid 19100532)
11. Conti C. R., Updated pathophysiologic concepts in unstable coronary artery disease American Heart Journal 2001 141 2 S12 S14
12. Dupuis J., Mechanisms of acute coronary syndromes and the potential role of statins Atherosclerosis Supplements 2001 2 1 9 14 (Pubitemid 38234466)
13. Koh K. K., Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability Cardiovascular Research 2000 47 4 648 657
14. Serruys P. W., Kutryk M. J. B., Ong A. T. L., Coronary-artery stents New England Journal of Medicine 2006 354 5 483 495 (Pubitemid 43200299)
15. Kullo I. J., Edwards W. D., Schwartz R. S., Vulnerable plaque: Pathobiology and clinical implications Annals of Internal Medicine 1998 129 12 1050 1060 (Pubitemid 29005830)
16. Ozer K., Cilingiroglu M., Vulnerable plaque: Definition, detection, treatment, and future implications Current Atherosclerosis Reports 2005 7 2 121 126
17. Steinberg D., Joseph L., Witztum J. L., Lipoproteins and atherogenesis. Current concepts Journal of the American Medical Association 1990 264 23 3047 3052
18. Ross R., Atherosclerosisan inflammatory disease New England Journal of Medicine 1999 340 2 115 126
19. Wilson A. M., Ryan M. C., Boyle A. J., The novel role of C-reactive protein in cardiovascular disease: Risk marker or pathogen International Journal of Cardiology 2006 106 3 291 297 (Pubitemid 41766629)
20. Naghavi M., Libby P., Falk E., Casscells S. W., Litovsky S., Rumberger J., Badimon J. J., Stefanadis C., Moreno P., Pasterkamp G., Fayad Z., Stone P. H., Waxman S., Raggi P., Madjid M., Zarrabi A., Burke A., Yuan C., Fitzgerald P. J., Siscovick D. S., De Korte C. L., Aikawa M., Airaksinen K. E. J., Assmann G., Becker C. R., Chesebro J. H., Farb A., Galis Z. S., Jackson C., Jang I. K., Koenig W., Lodder R. A., March K., Demirovic J., Navab M., Priori S. G., Rekhter M. D., Bahr R., Grundy S. M., Mehran R., Colombo A., Boerwinkle E., Ballantyne C., Insull W., Schwartz R. S., Vogel R., Serruys P. W., Hansson G. K., Faxon D. P., Kaul S., Drexler H., Greenland P., Muller J. E., Virmani R., Ridker P. M., Zipes D. P., Shah P. K., Willerson J. T., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I Circulation 2003 108 14 1664 1672 (Pubitemid 37243650)
21. Naghavi M., Libby P., Falk E., Casscells S. W., Litovsky S., Rumberger J., Badimon J. J., Stefanadis C., Moreno P., Pasterkamp G., Fayad Z., Stone P. H., Waxman S., Raggi P., Madjid M., Zarrabi A., Burke A., Yuan C., Fitzgerald P. J., Siscovick D. S., De Korte C. L., Aikawa M., Airaksinen K. E. J., Assmann G., Becker C. R., Chesebro J. H., Farb A., Galis Z. S., Jackson C., Jang I. K., Koenig W., Lodder R. A., March K., Demirovic J., Navab M., Priori S. G., Rekhter M. D., Bahr R., Grundy S. M., Mehran R., Colombo A., Boerwinkle E., Ballantyne C., Insull W., Schwartz R. S., Vogel R., Serruys P. W., Hansson G. K., Faxon D. P., Kaul S., Drexler H., Greenland P., Muller J. E., Virmani R., Ridker P. M., Zipes D. P., Shah P. K., Willerson J. T., From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: part II Circulation 2003 108 15 1772 1778 (Pubitemid 37296082)
22. Wen C., Xu H., Huang Q. F., Chen K. J., Effect of drugs for promoting blood circulation on blood lipids and inflammatory reaction of atherosclerotic plaques in ApoE gene deficiency mice Chinese Journal of Integrated Traditional and Western Medicine 2005 25 4 345 349
23. Wen C., Xu H., Huang Q. F., Chen K. J., Effects of herbs for promoting blood circulation and Xiongshao Capsule on collagen deposition and metabolism of atherosclerotic plaques in ApoE gene deficient mice Chinese Journal of Pathophysiology 2005 21 8 1640
24. Xu H., Wen C., Chen K. J., Shi D. Z., Liu J. G., Study on the effect of rhizoma Chuanxiong, radix paeoniae rubra and the compound of their active ingredients, Xiongshao Capsule, on stability of atherosclerotic plaque in ApoE(-/-) mice Chinese Journal of Integrated Traditional and Western Medicine 2007 27 6 513 518
25. Xu H., Qu D., Zheng F., Shi D. Z., Chen K. J., Clinical manifestations of blood-stasis and toxin in patients with stable coronary heart disease Chinese Journal of Integrated Traditional and Western Medicine 2010 30 2 125 129
26. Feng Y., Xu H., Qu D., Zheng F., Shi D.Z., Chen K.J., Study on the tongue manifestations for the blood-stasis and toxin syndrome in the stable patients of coronary heart disease Chinese Journal of Integrative Medicine 2011 17 5 333 338
27. Chen K. J., Shi D. Z., Xu H., Yin H. J., Zhang J. C., The criterion of syndrome differentiation and quantification for stable coronary heart disease caused by etiological toxin of Chinese medicine Chinese Journal of Integrated Traditional and Western Medicine 2011 31 3 313 314